Thirteen 2-oxazine-based small molecules were synthesized targeting 5-lipoxygenase (LOX), and acetylcholinesterase (AChE). The test revealed that the newly synthesized compounds had potent inhibition towards both 5-LOX and AChE in lower micro molar concentration. Among the tested compounds, the most active compound, 2-(2-acetyl-6,6-dimethyl-4-phenyl-5,6-dihydro-2H-1,2-oxazin-3- yl)methyl-1H-isoindole-1,3(2H)-dione (2a) showed inhibitory activity towards 5-LOX and AChE with an IC50 values of 1.88, and 2.5 μM, respectively. Further, the in silico molecular docking studies revealed that the compound 2a bound to the catalytic domain of AChE strongly with a highest CDOCKER score of -1.18 kcal/mol when compared to other compounds of the same ser...
In this work, a novel series of arylisoxazole-phenylpiperazines were designed, synthesized, and eval...
Alzheimer’s disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and c...
Cholinesterase inhibitors (ChE-Is) are the standard for the therapy of AD associated disorders and a...
Thirteen 2-oxazine-based small molecules were synthesized targeting 5-lipoxygenase (LOX), and acetyl...
Alzheimer’s disease (AD) is a neurodegenerative disease that causes memory and cognitive decline as ...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive ...
Comunicação oral sob a forma de painelAlzheimer’s disease (AD) is the most common form of dementia a...
A series of sulfone analogs of donepezil were designed and synthesized as novel acetylcholinesterase...
Aiming at modulating two key enzymatic targets for Alzheimer's disease (AD), i.e., acetylcholinester...
A series of novel 4-isochromanone compounds bearing N-benzyl pyridinium moiety were designed and syn...
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the leading cause of dementia ...
In the past few decades, the cholinergic theory of Alzheimer's disease has been promoted as a crucia...
none18siNeuroinflammation and cholinergic deficit are key detrimental processes involved in Alzheime...
As part of an in-house project, the CSIR-housed BioFocus library composed of approximately 20’000 th...
WOS: 000421186100002The aim of this work was to investigate the new effective agents candidate for t...
In this work, a novel series of arylisoxazole-phenylpiperazines were designed, synthesized, and eval...
Alzheimer’s disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and c...
Cholinesterase inhibitors (ChE-Is) are the standard for the therapy of AD associated disorders and a...
Thirteen 2-oxazine-based small molecules were synthesized targeting 5-lipoxygenase (LOX), and acetyl...
Alzheimer’s disease (AD) is a neurodegenerative disease that causes memory and cognitive decline as ...
Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by progressive ...
Comunicação oral sob a forma de painelAlzheimer’s disease (AD) is the most common form of dementia a...
A series of sulfone analogs of donepezil were designed and synthesized as novel acetylcholinesterase...
Aiming at modulating two key enzymatic targets for Alzheimer's disease (AD), i.e., acetylcholinester...
A series of novel 4-isochromanone compounds bearing N-benzyl pyridinium moiety were designed and syn...
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the leading cause of dementia ...
In the past few decades, the cholinergic theory of Alzheimer's disease has been promoted as a crucia...
none18siNeuroinflammation and cholinergic deficit are key detrimental processes involved in Alzheime...
As part of an in-house project, the CSIR-housed BioFocus library composed of approximately 20’000 th...
WOS: 000421186100002The aim of this work was to investigate the new effective agents candidate for t...
In this work, a novel series of arylisoxazole-phenylpiperazines were designed, synthesized, and eval...
Alzheimer’s disease (AD) is a neurodegenerative disorder mostly influencing the elderly, and c...
Cholinesterase inhibitors (ChE-Is) are the standard for the therapy of AD associated disorders and a...